Inventor
MERCHANT FAHAR
CA16 patents
⚠️ This page may combine multiple inventors who share the name “MERCHANT FAHAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDICENNA THERAPEUTICS INC
11 patentsUS10781242B2Sep 22, 2020
Interleukin-2 fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC5 citations82
US10106592B2Oct 23, 2018
Interleukin-4 receptor-binding fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC8 citations82
US10093708B2Oct 9, 2018
Interleukin-4 receptor-binding fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC9 citations82
US11680090B2Jun 20, 2023
Interleukin-2 fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC3 citations71
US11084856B2Aug 10, 2021
Interleukin-4 receptor-binding fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC1 citations69
US12404497B2Sep 2, 2025
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
MEDICENNA THERAPEUTICS INC0 citations61
US12274735B2Apr 15, 2025
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
MEDICENNA THERAPEUTICS INC0 citations61
US12503496B2Dec 23, 2025
Interleukin-4 receptor-binding fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC0 citations59
US12338269B2Jun 24, 2025
IL-2 superagonists in combination with anti-PD-1 antibodies
MEDICENNA THERAPEUTICS INC0 citations59
US11542312B2Jan 3, 2023
IL-2 superagonists in combination with anti-PD-1 antibodies
MEDICENNA THERAPEUTICS INC1 citations59
US11352402B2Jun 7, 2022
Interleukin-4 receptor-binding fusion proteins and uses thereof
MEDICENNA THERAPEUTICS INC0 citations59